Skip to main content

Table 4 Maternal characteristics of the patients in the control and RIF groups of the frozen-thawed ET cycles (n=105)

From: Is there any difference between the obstetric and perinatal complications of pregnancy in patients with and without repeated implantation failure in fresh and frozen-thawed embryo transfer cycles?

Variables

Control (n=49)

RIF (n=56)

P-value

Age (yr.)

28.67 ± 4.02

30.01 ± 4.14

0.09

AMH (ng/ml)a

6.70 (5.59)

3.1 (2.53)

0.06

Cycle daya

17.00 (1.00)

18.00 (2.00)

0.44

Gonadotropin dose (IU)a

1500.00 (825.00)

1350.00 (768.75)

0.95

Duration of infertility (yr.)

8.04 ± 4.03

9.01 ± 4.27

0.23

Protocols

 Agonist

5 (10.2)

9 (16.1)

0.67

 Antagonist

40 (81.6)

43 (76.8)

 Micro dose

4 (8.2)

4 (7.1)

Trigger

 HCG

24 (49)

32 (57.1)

0.69

 Agonist

15 (30.6)

15 (26.8)

 Double

10 (20.4)

9 (16.1)

Number of ET

 1

3 (6.1)

10 (17.9)

0.18

 2

35 (71.4)

36 (64.3)

 3

11 (22.4)

10 (17.9)

Indications for IVF treatment

 Male factor

19 (38.8)

24 (42.9)

0.81

 Female factor

18 (36.7)

16 (28.6)

 Unexplained factor

3 (6.1)

5 (8.9)

 Male and female factors

9 (18.4)

11 (19.6)

Type of infertility

 Primary

42 (85.7)

51 (91.1)

0.54

 Secondary

7 (14.3)

5 (8.9)

  1. The parametric data were presented with mean ± SD. aNon-parametric data were presented with median (interquartile range). The numerical data were presented with frequency (percent). P < 0.05 was considered as significant. AMH anti-Mullerian hormone, ET embryo transfer